Global drug pricing isn’t just a policy issue—it’s a business-critical variable that affects every player in the pharmaceutical value chain. FromRead More

The pharma environment is seeing a major shift with the introduction of biologics. These complicated, large-molecule medicines are slowly becoming center stage alongside classical small molecules.Read More

Getting new drugs approved is not easy. The medical field moves really fast, and there are many steps. One big part of this is scientific regulatory writing.Read More

Gain insights into the FDA Early Warning System, its role in detecting drug safety issues, ensuring public health, and promoting transparency in healthcare.Read More

Discover the key reasons behind assay increase during drug product stability studies, including factors like degradation, impurities, and formulation changes.Read More